Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Palestine flag Palestine · Delayed Price · Currency is JOD · Price in USD
4.640
+0.040 (0.87%)
At close: Feb 11, 2026
Market Cap59.20M +40.6%
Revenue (ttm)33.42M +25.9%
Net Income6.98M +139.5%
EPS0.39 +138.9%
Shares Out18.00M
PE Ratio8.49
Forward PEn/a
Dividend0.06 (1.72%)
Ex-Dividend DateApr 30, 2025
Volume300
Average Volume2,443
Open4.650
Previous Close4.600
Day's Range4.640 - 4.650
52-Week Range3.550 - 4.820
Beta-0.02
RSI55.21
Earnings DateMar 26, 2026

About Jerusalem Pharmaceuticals

Jerusalem Pharmaceuticals Co. Ltd., together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. The company offers over the counter, prescription pharmaceutical, and nutritional supplements products in various dosage forms, including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, and ointments, as well as ear and nose drops and solutions. It also provides medical devices... [Read more]

Industry Pharmaceutical Preparations
Founded 1969
Employees 531
Stock Exchange Palestine Stock Exchange
Ticker Symbol JPH
Full Company Profile

Financial Performance

In 2024, Jerusalem Pharmaceuticals's revenue was $39.82 million, an increase of 0.42% compared to the previous year's $39.65 million. Earnings were $5.04 million, a decrease of -27.58%.

Financial numbers in USD Financial Statements